Modulation of survivin-caspase-9 complex by survivin phosphorylation on
Thr34. (A) Immunoprecipitation from
nonadherent cells. HeLa cells transfected with HA-survivin (WT) or
HA-survivin(T34A) (T34A) were harvested after mitotic shake off,
immunoprecipitated with anti-HA followed by Western blotting (WB) with
an antibody to caspase-9 (casp.9). (B)
Immunoprecipitation from synchronized cells. HeLa cells were
transfected with HA-survivin (WT) or HA-survivin(T34A) (T34A),
immunoprecipitated with anti-HA 12-h after thymidine release, and
analyzed for coassociated caspase-9 by Western blotting. Arrows,
position of 46-kDa proform caspase-9 and ≈35-kDa active caspase-9. P,
pellet; S, supernatant. (A and B) Blots
were sequentially immunoblotted with anti-HA. (C)
Mislocalization of caspase-9 from midbodies in
survivin(T34A)-expressing cells. HeLa cells transfected with
HA-survivin (Survivin), survivin(T34A), or survivin(L64A) were labeled
for survivin (FITC, green) with a mAb to HA or mAb 8E2
(Bottom), and caspase-9 (Casp.9, TR, red), and analyzed
by confocal microscopy. Image-merging analysis is shown on the right.
Arrows, differential localization of wild-type survivin,
survivin(T34A), or survivin(L64A) with caspase-9 at midbodies.
Experiments were repeated at least four times with comparable results.
(D) Apoptosis in survivin(T34A)-expressing cells
is mediated by caspase-9. HeLa cells transfected with the various
indicated combinations of GFP-constructs, with or without etoposide (10
μg/ml) or TNFα (TNF, 10 ng/ml) plus cycloheximide (CHX, 10
μg/ml), were morphologically scored for nuclear fragmentation by
DAPI staining. DN, dominant negative. *, P
< 0.05; ***, P < 0.0005.
Data are the mean ± SEM of four independent experiments.